Statin therapy is associated with lower prevalence of gut microbiota dysbiosis

Vieira‐Silva, S., Falony, G., Belda, E., Nielsen, T., Aron‐Wisnewsky, J., Chakaroun, R., Forslund, S.K., Assmann, K.E., Valles‐Colomer, M., Nguyen, T.T.D., Proost, S., Prifti, E., Tremaroli, V., Pons, N., Chatelier, E.L., Andreelli, F., Bastard, J., Coelho, L.P., Galleron, N., &amp; Hansen, T.H. (2020). Statin therapy is associated with lower prevalence of gut microbiota dysbiosis. <em>Nature</em>. https://doi.org/10.1038/s41586-020-2269-x

Vieira‐Silva S, Falony G, Belda E, Nielsen T, Aron‐Wisnewsky J, Chakaroun R, et al. Statin therapy is associated with lower prevalence of gut microbiota dysbiosis. Nature. 2020. doi:10.1038/s41586-020-2269-x.

@unpublished{sara2020Statin, title = {Statin therapy is associated with lower prevalence of gut microbiota dysbiosis}, author = {Sara Vieira‐Silva and Gwen Falony and Eugeni Belda and Trine Nielsen and Judith Aron‐Wisnewsky and Rima Chakaroun and Sofia K. Forslund and Karen E. Assmann and Mireia Valles‐Colomer and Thi Thuy Duyen Nguyen and Sebastian Proost and Edi Prifti and Valentina Tremaroli and Nicolas Pons and Emmanuelle Le Chatelier and Fabrizio Andreelli and Jean-Phillippe Bastard and Luís Pedro Coelho and Nathalie Galleron and Tue H. Hansen and Jean‐Sébastien Hulot and Christian Lewinter and Helle Pedersen and Benoît Quinquis and Christine Rouault}, journal = {Nature}, year = {2020}, doi = {10.1038/s41586-020-2269-x}, }